Matching placebo to KX-826

DRUG2 trials

Sponsors

Suzhou Kintor Pharmaceutical Inc,, Suzhou Koshine Biomedica, Inc.

Conditions

AlopeciaMale Pattern Hair Loss

Phase 2

To Evaluate Efficacy, Safety, and Tolerability of KX-826 in Male Subjects With Androgenetic Alopecia

CompletedNCT05218642

Suzhou Kintor Pharmaceutical Inc,Alopecia, Male Pattern Hair Loss

Start: 2022-01-31End: 2023-02-13Updated: 2023-11-22

To Evaluate Safety and Efficacy of KX-826 in Chinese Female Subjects With Androgenetic Alopecia

CompletedNCT06409650

Suzhou Koshine Biomedica, Inc.Alopecia

Start: 2021-11-09End: 2023-12-07Updated: 2024-05-22